Clinical trial
Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant…
NCT00235651 · University of Pittsburgh, Other · Terminated
Key facts
| NCT number | NCT00235651 |
|---|---|
| Title | Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant Recipients |
| Official title | Pharmacokinetic and Deposition Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet®) in Lung Transplant Recipients (Radiotagging Protocol) |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Enzon Pharmaceuticals, Inc. Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Transplantation, Lung Diseases |
| Intervention type | Drug |
| Interventions | Amphotericin B |
| Enrollment | 12 |
| Start date | Oct 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Oct 10, 2005 |
| Last update posted | Dec 17, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: